Company Filing History:
Years Active: 2013
Title: Bénédicte Dupas: Innovator in Angiogenesis Modulation
Introduction
Bénédicte Dupas is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the modulation of angiogenesis. His innovative work has the potential to impact therapeutic approaches for various medical conditions.
Latest Patents
Bénédicte Dupas holds a patent titled "Methods for modulating angiogenesis via dystrophin Dp71." This invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention highlights the role of Dp71 in angiogenesis and provides novel therapeutic approaches. It also introduces methods for screening agents that modulate angiogenesis, specifically targeting this protein. The patent outlines the use of Dp71 or its variants for stimulating angiogenesis in subjects, particularly humans. Additionally, it discusses the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject.
Career Highlights
Bénédicte Dupas is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has led to advancements in understanding the mechanisms of angiogenesis and its implications for medical treatments.
Collaborations
Some of his notable coworkers include Romain Bernard and Alain Gaudric. Their collaborative efforts contribute to the ongoing research and development in the field of angiogenesis.
Conclusion
Bénédicte Dupas is a key figure in the innovation of angiogenesis modulation, with a patent that opens new avenues for therapeutic interventions. His contributions to medical research are invaluable and continue to shape the future of treatment strategies.